Abstract

B cells are a group of diverse phenotype and function subsets, which can both stimulate and inhibit the immune response to an allograft. They participate in the rejection process by influencing differentiation, proliferation and effector functions of T lymphocytes. B cells injure the graft via the ADCC (antibody-dependent cellular cytotoxicity) reaction and humoral rejection through plasmocyte production of donor-specific antibodies.A converse, suppressive mode of B cells can attribute to the development of tolerance and protect the graft from rejection. This function is provided by the regulatory B cells, which negatively control the immune response by producing suppressor cytokines (IL-10, IL-35, TGF-β), natural antibodies and through cellular interactions. In effect they inhibit the development of Th1 and Th17 effector cells, and induce differentiation of regulatory T cells.Operational immune tolerance in human kidney transplant recipients was associated with increased number of naïve and transitional B cells of regulatory function, and increased gene expression for differentiation of B cells. However, in chronic alloantibody transplant rejection the distorted distribution and function of regulatory B cells was found, which implies their pivotal role in graft tolerance.Currently, the immunosuppressive regimens unselectively inhibit the activity of T and B cells, by interfering with their effector and immunoregulatory functions. They do not fully control the chronic rejection reaction, which is the major cause of graft loss. Comprehension of the mechanisms of immunologic homeostasis dependent on B cells can help develop immunosuppressive protocols targeted at tolerance.

References

• 1. Agematsu K., Hokibara S., Nagumo H., Komiyama A.: CD27: a memoryB-cell marker. Immunol. Today, 2000; 21: 204-206
  Google Scholar
• 2. Baba Y., Matsumoto M., Kurosaki T.: Signals controlling the developmentand activity of regulatory B-lineage cells. Int. Immunol.,2015; 27: 487-493
  Google Scholar
• 3. Banasik M., Boratyńska M., Kościelska-Kasprzak K., MazanowskaO., Bartoszek D., Zabińska M., Myszka M., Nowakowska B., Hałoń A.,Szyber P., Patrzałek D., Klinger M.: Long-term follow-up of non-HLAand anti-HLA antibodies: incidence and importance in renal transplantation.Transplant. Proc., 2013; 45: 1462-1465
  Google Scholar
• 4. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A.,Ehrenstein M.R., Mauri C.: CD19+CD24hiCD38hi B cells exhibit regulatorycapacity in healthy individuals but are functionally impaired insystemic Lupus Erythematosus patients. Immunity, 2010; 32: 129-140
  Google Scholar
• 5. Bohana-Kashtan O., Civin C.I.: Fas ligand as a tool for immunosuppressionand generation of immune tolerance. Stem Cells, 2004;22: 908-924
  Google Scholar
• 6. Brouard S., Le Bars A., Dufay A., Gosselin M., Foucher Y., GuilletM., Cesbron-Gautier A., Thervet E., Legendre C., Dugast E., Pallier A.,Guillot-Gueguen C., Lagoutte L., Evanno G., Giral M., Soulillou J.P.:Identification of a gene expression profile associated with operationaltolerance among a selected group of stable kidney transplantpatients. Transpl. Int., 2011; 24: 536-547
  Google Scholar
• 7. Brouard S., Pallier A., Renaudin K., Foucher Y., Danger R., DevysA., Cesbron A., Guillot-Guegen C., Ashton-Chess J., Le Roux S., HarbJ., Roussey G., Subra J.F., Villemain F., Legendre C. i wsp.: The naturalhistory of clinical operational tolerance after kidney transplantationthrough twenty-seven cases. Am. J. Transplant., 2012; 12: 3296-3307
  Google Scholar
• 8. Candando K.M., Lykken J.M., Tedder T.F.: B10 cell regulation ofhealth and disease. Immunol. Rev., 2014; 259: 259-272
  Google Scholar
• 9. Capolunghi F., Cascioli S., Giorda E., Rosado M.M., Plebani A., AuritiC., Seganti G., Zuntini R., Ferrari S., Cagliuso M., Quinti I., CarsettiR.: CpG drives human transitional B cells to terminal differentiationand production of natural antibodies. J. Immunol., 2008; 180: 800-808
  Google Scholar
• 10. Carsetti R., Rosado M.M., Wardmann H.: Peripheral developmentof B cells in mouse and man. Immunol. Rev., 2004; 197: 179-191
  Google Scholar
• 11. Chapman J.R.: Clinical renal transplantation: where are we now,what are our key challenges? Transplant. Proc., 2010; 42 (Suppl.9): S3-S6
  Google Scholar
• 12. Chen X., Jensen P.E.: Cutting edge: primary B lymphocytes preferentiallyexpand allogeneic FoxP3+ CD4 T cells. J. Immunol., 2007;179: 2046-2050
  Google Scholar
• 13. Cherukuri A., Rothstein D.M., Clark B., Carter C.R., Davison A.,Hernandez-Fuentes M., Hewitt E., Salama A.D., Baker R.J.: Immunologichuman renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells. J. Am. Soc. Nephrol.,2014; 25: 1575-1585
  Google Scholar
• 14. Chesneau M., Michel L., Dugast E., Chenouard A., Baron D., PallierA., Durand J., Braza F., Guerif P., Laplaud D.A., Soulillou J.P., GiralM., Degauque N., Chiffoleau E., Brouard S:. Tolerant kidney transplantpatients produce B Cells with regulatory properties. J. Am.Soc. Nephrol., 2015; 26: 2588-2598
  Google Scholar
• 15. Chesneau M., Pallier A., Braza F., Lacombe G., Le Gallou S., BaronD., Giral M., Danger R., Guerif P., Aubert-Wastiaux H., Neel A., MichelL., Laplaud D.A., Degauque N., Soulillou J.P., Tarte K., BrouardS.: Unique B cell differentiation profile in tolerant kidney transplantpatients. Am. J. Transplant., 2014; 14: 144-155
  Google Scholar
• 16. Chung B.H., Kim K.W., Yu J.H., Kim B.M., Choi B.S., Park C.W.,Kim Y.S., Cho M.L., Yang C.W.: Decrease of immature B cell and interleukin-10during early-post-transplant period in renal transplantrecipients under tacrolimus based immunosuppression. Transpl.Immunol., 2014; 30: 159-167
  Google Scholar
• 17. Clatworthy M.R., Watson C.J., Plotnek G., Bardsley V., ChaudhryA.N., Bradley J.A., Smith K.G.: B-cell-depleting induction therapyand acute cellular rejection. N. Engl. J. Med., 2009; 360: 2683-2685
  Google Scholar
• 18. Cobaleda C., Schebesta A., Delogu A., Busslinger M.: Pax5: theguardian of B cell identity and function. Nat. Immunol., 2007; 8:463-470
  Google Scholar
• 19. Cooper M.D.: Exploring lymphocyte differentiation pathways.Immunol. Rev., 2002; 185: 175-185
  Google Scholar
• 20. De Bruyne R., Bogaert D., De Ruyck N., Lambrecht B.N., VanWinckel M., Gevaert P., Dullaers M.: Calcineurin inhibitors dampenhumoral immunity by acting directly on naive B cells. Clin. Exp. Immunol.,2015; 180: 542-550
  Google Scholar
• 21. Dharnidharka V.R., Lamb K.E., Zheng J., Schechtman K.B., Meier-KriescheH.U.: Lack of significant improvements in long-termallograft survival in pediatric solid organ transplantation: a US nationalregistry analysis. Pediatr. Transplant., 2015; 19: 477-483
  Google Scholar
• 22. DiLillo D.J., Griffiths R., Seshan S.V., Magro C.M., Ruiz P., CoffmanT.M., Tedder T.F.: B lymphocytes differentially influence acute andchronic allograft rejection in mice. J. Immunol., 2011; 186: 2643-2654
  Google Scholar
• 23. DiLillo D.J., Matsushita T., Tedder T.F.: B10 cells and regulatoryB cells balance immune responses during inflammation, autoimmunity,and cancer. Ann. N. Y. Acad. Sci., 2010; 1183: 38-57
  Google Scholar
• 24. Ding Q., Yeung M., Camirand G., Zeng Q., Akiba H., Yagita H.,Chalasani G., Sayegh M.H., Najafian N., Rothstein D.M.: RegulatoryB cells are identified by expression of TIM-1 and can be inducedthrough TIM-1 ligation to promote tolerance in mice. J. Clin. Invest.,2011; 121: 3645-3656
  Google Scholar
• 25. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A.,Rawlings D.J., Ehrenstein M.R., Mauri C.: Novel suppressive functionof transitional 2 B cells in experimental arthritis. J. Immunol.,2007; 178: 7868-7878
  Google Scholar
• 26. Feliksbrot M.E., Król M.A., Dwilewicz-Trojaczek J.: Limfopoezakomórek B u człowieka. Adv. Clin. Exp. Med., 2005; 14: 1033-1040
  Google Scholar
• 27. Gray D., Gray M.: What are regulatory B cells? Eur. J. Immunol.,2010; 40: 2677-2679
  Google Scholar
• 28. Hagn M., Schwesinger E., Ebel V., Sontheimer K., Maier J., BeyerT., Syrovets T., Laumonnier Y., Fabricius D., Simmet T., Jahrsdörfer B.: Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol.,2009; 183: 1838-1845
  Google Scholar
• 60. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., SuthanthiranM., Burlingham W.J., Marks W.H., Sanz I., Lechler R.I., Hernandez-FuentesM.P., Turka L.A., Seyfert-Margolis V.L., ImmuneTolerance Network ST507 Study Group: Identification of a B cellsignature associated with renal transplant tolerance in humans. J.Clin. Invest., 2010; 120: 1836-1847
  Google Scholar
• 61. Nouël A., Ségalen I., Jamin C., Doucet L., Caillard S., RenaudineauY., Pers J.O., Le Meur Y., Hillion S.: B cells display an abnormaldistribution and an impaired suppressive function in patients withchronic antibody-mediated rejection. Kidney Int. 2014; 85: 590-599
  Google Scholar
• 62. Nouël A., Simon Q., Jamin C., Pers J.O., Hillion S.: Regulatory Bcells: an exciting target for future therapeutics in transplantation.Front. Immunol., 2014; 5: 11
  Google Scholar
• 63. Nova-Lamperti E., Fanelli G., Becker P.D., Chana P., ElguetaR., Dodd P.C., Lord GM., Lombardi G., Hernandez-Fuentes M.P.: IL-10-produced by human transitional B-cells down-regulates CD86expression on B-cells leading to inhibition of CD4+T-cell responses.Sci. Rep., 2016; 6: 20044
  Google Scholar
• 64. Olkhanud P.B., Damdinsuren B., Bodogai M., Gress R.E., Sen R.,Wejksza K., Malchinkhuu E., Wersto R.P., Biragyn A.: Tumor-evokedregulatory B cells promote breast cancer metastasis by convertingresting CD4⁺ T cells to T-regulatory cells. Cancer Res., 2011; 71:3505-3515
  Google Scholar
• 65. Pallier, A., Hillion S., Danger R., Giral M., Racapé M., Degauque N.,Dugast E., Ashton-Chess J., Pettré S., Lozano J.J., Bataille R., Devys A.,Cesbron-Gautier A., Braudeau C., Larrose C., Soulillou J.P., Brouard S.:Patients with drug-free long-term graft function display increasednumbers of peripheral B cells with a memory and inhibitory phenotype.Kidney Int., 2010; 78: 503-513
  Google Scholar
• 66. Qian L., Qian C., Chen Y., Bai Y., Bao Y., Lu L., Cao X.: Regulatorydendritic cells program B cells to differentiate into CD19hiFcgIIbhiregulatory B cells through IFN-β and CD40L. Blood, 2012; 120: 581-591
  Google Scholar
• 67. Ray A., Wang L., Dittel B.N.: IL-10-independent regulatory B-cellsubsets and mechanisms of action. Int. Immunol., 2015; 27: 531-536
  Google Scholar
• 68. Rosser E.C., Mauri C.: Regulatory B cells: origin, phenotype, andfunction. Immunity, 2015; 42: 607-612
  Google Scholar
• 69. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., MiqueuP., Chapman S., Craciun L., Sergeant R., Brouard S., Rovis F.,Jimenez E., Ballow A., Giral M., Rebollo-Mesa I. i wsp.: Developmentof a cross-platform biomarker signature to detect renal transplanttolerance in humans. J. Clin. Invest., 2010; 120: 1848-1861
  Google Scholar
• 70. Shabir S., Girdlestone J., Briggs D., Kaul B., Smith H., Daga S.,Chand S., Jham S., Navarrete C., Harper L., Ball S., Borrows R.: TransitionalB lymphocytes are associated with protection from kidneyallograft rejection: a prospective study. Am. J. Transplant., 2015;15: 1384-1391
  Google Scholar
• 71. Shen P., Roch T., Lampropoulou V., O’Connor R.A., Stervbo U.,Hilgenberg E., Ries S., Dang V.D., Jaimes Y., Daridon C., Li R., JouneauL., Boudinot P., Wilantri S., Sakwa I. i wsp.: IL-35-producing B cellsare critical regulators of immunity during autoimmune and infectiousdiseases. Nature, 2014; 507: 366-370
  Google Scholar
• 72. Silva H.M., Takenaka M.C., Moraes-Vieira P.M., Monteiro S.M.,Hernandez M.O., Chaara W., Six A., Agena F., Sesterheim P., Barbé–Tuana F.M., Saitovitch D., Lemos F., Kalil J., Coelho V.: Preservingthe B-cell compartment favors operational tolerance in human renaltransplantation. Mol. Med., 2012; 18: 733-743
  Google Scholar
• 73. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., LipskyP.E.: Identification and characterization of circulating human transitionalB cells. Blood, 2005; 105: 4390-4398
  Google Scholar
• 74. Svachova V., Sekerkova A., Hruba P., Tycova I., Rodova M., CecrdlovaE., Slatinska J., Honsova E., Striz I., Viklicky O.: Dynamicchanges of B-cell compartments in kidney transplantation: lack oftransitional B cells is associated with allograft rejection. Transpl.Int., 2016; 29: 540-548
  Google Scholar
• 75. Tedder T.F.: B10 cells: a functionally defined regulatory B cellsubset. J. Immunol., 2015; 194: 1395-1401
  Google Scholar
• 76. Todeschini M., Cortinovis M., Perico N., Poli F., Innocente A.,Cavinato R.A., Gotti E., Ruggenenti P., Gaspari F., Noris M., RemuzziG., Casiraghi F.: In kidney transplant patients, alemtuzumab but notbasiliximab/low-dose rabbit anti-thymocyte globulin induces B celldepletion and regeneration, which associates with a high incidenceof de novo donor-specific anti-HLA antibody development. J. Immunol.,2013; 191: 2818-2828
  Google Scholar
• 77. van de Berg P.J., Hoevenaars E.C., Yong S.L., van Donselaar-vander Pant K.A., van Tellingen A., Florquin S., van Lier R.A., BemelmanF.J., ten Berge I.J.: Circulating lymphocyte subsets in different clinicalsituations after renal transplantation. Immunology, 2012; 136: 198-207
  Google Scholar
• 78. van de Veen W., Stanic B., Yaman G., Wawrzyniak M., Söllner S., AkdisD.G., Rückert B., Akdis C.A., Akdis M.: IgG4 production is confined tohuman IL-10-producing regulatory B cells that suppress antigen-specificimmune responses. J. Allergy Clin. Immunol., 2013; 131: 1204-1212
  Google Scholar
• 79. Viklicky O., Krystufkova E., Brabcova I., Sekerkova A., Wohlfahrt P.,Hribova P., Wohlfahrtova M., Sawitzki B., Slatinska J., Striz I., Volk H.D.,Reinke P.: B-cell-related biomarkers of tolerance are up-regulated in rejection-freekidney transplant recipients. Transplantation, 2013; 95: 148-154
  Google Scholar
• 80. Walsh L., Dinavahi R.: Current unmet needs in renal transplantation:a review of challenges and therapeutics. Front. Biosci., 2016; 8: 1-14
  Google Scholar
• 81. Wang R.X., Yu C.R., Dambuza I.M., Mahdi R.M., Dolinska M.B.,Sergeev Y.V., Wingfield P.T., Kim S.H., Egwuagu C.E.: Interleukin-35induces regulatory B cells that suppress autoimmune disease. Nat.Med., 2014; 20: 633-641
  Google Scholar
• 82. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A.Jr.: Experimentalautoimmune encephalomyelitis induction in genetically Bcell-deficient mice. J. Exp. Med., 1996; 184: 2271-2278
  Google Scholar
• 83. Wootla B., Nicoletti A., Patey N., Dimitrov J.D., Legendre C., ChristopheO.D., Friboulet A., Kaveri S.V., Lacroix-Desmazes S., ThaunatO.: Hydrolysis of coagulation factors by circulating IgG is associatedwith a reduced risk for chronic allograft nephropathy in renal transplantedpatients. J. Immunol., 2008; 180: 8455-8460
  Google Scholar
• 84. Yan Y., van der Putten K., Bowen D.G., Painter D.M., Kohar J.,Sharland A.F., McCaughan G.W., Bishop G.A.: Postoperative administrationof donor B cells induces rat kidney allograft acceptance: lackof association with Th2 cytokine expression in long-term acceptedgrafts. Transplantation, 2002; 73: 1123-1130
  Google Scholar
• 85. Yanaba K., Bouaziz J.D., Matsushita T., Magro C.M., St Clair E.W.,Tedder T.F.: B-lymphocyte contributions to human autoimmune disease.Immunol. Rev., 2008; 223: 284-299
  Google Scholar
• 86. Yanaba K., Hamaguchi Y., Venturi G.M., Steeber D.A., St ClairE.W., Tedder T.F.: B cell depletion delays collagen-induced arthritisin mice: arthritis induction requires synergy between humoral andcell-mediated immunity. J. Immunol., 2007; 179: 1369-1380
  Google Scholar
• 87. Yang M., Deng J., Liu Y., Ko K.H., Wang X., Jiao Z., Wang S., Hua Z.,Sun L., Srivastava G., Lau C.S., Cao X., Lu L.: IL-10-producing regulatoryB10 cells ameliorate collagen-induced arthritis via suppressingTh17 cell generation. Am. J. Pathol., 2012; 180: 2375-2385
  Google Scholar
• 88. Zand M.S., Vo T., Huggins J., Felgar R., Liesveld J., Pellegrin T.,Bozorgzadeh A., Sanz I., Briggs B.J.: Polyclonal rabbit antithymocyteglobulin triggers B-cell and plasma cell apoptosis by multiple pathways.Transplantation, 2005; 79: 1507-1515
  Google Scholar
• 89. Zarkhin V., Lovelace P.A., Li L., Hsieh S.C., Sarwal M.M.: Phenotypicevaluation of B-cell subsets after rituximab for treatment ofacute renal allograft rejection in pediatric recipients. Transplantation,2011; 91: 1010-1018
  Google Scholar
• 90. Zhang Y., Gallastegui N., Rosenblatt J.D.: Regulatory B cells inanti-tumor immunity. Int. Immunol., 2015; 27: 521-530
  Google Scholar

Full text